Morphic Holding, Inc.

Submit Your Information

Company Name	Morphic Holding, Inc.
Stock Symbol	MORF

On September 22, 2023, Morphic issued a press release announcing publication of an abstract discussing the Company’s EMERALD-1 phase 2a primary results. The Company revealed disappointing results, including that “endoscopic improvement was achieved in 25.7% of patients at week 12,” which was less than the 41% shown by Entyvio.

On this news, Morphic’s stock price fell $28.26, or 54.4%, over two consecutive trading days to close at $23.14 per share on September 25, 2023, thereby injuring investors.

Submit Your Information

If you suffered a loss on your Morphic Holding, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before January 01, 1970?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments